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The role of MR imaging in rectal cancer is well established in clinical practice but standard 
assessment has limitations. This thesis investigates new MR imaging methods and their diagnostic 
relevance in patient staging and management. It is divided in 2 parts: Part I focuses on lymph node 
staging and Part II focuses on the patterns of sustained clinical complete response after neoadjuvant 
therapy in locally-advanced rectal cancer patients.  
Part I: Pelvic MR imaging is the pillar of rectal cancer staging and the basis for optimal 
multidisciplinary patient management. A thorough and systematic knowledge of the relevant 
anatomy, the key staging features and the particularities of early, low and mucinous tumours is 
mandatory for MR imaging interpretation and is provided as an educational review.  
Lymph node status is one of the key staging features for risk stratification, but evaluation is 
hampered by limited MR imaging accuracy. Two new methodologies - Susceptibility Perturbation 
MR Imaging and Higher-order Diffusion MR Imaging - are introduced as original research. These 
methods were tested ex-vivo at ultra-high field (16.4 Tesla) in mesorectal lymph nodes and the 
mechanisms underlying the emerging contrasts were elucidated using quantitative histology. The 
experiments were then translated in-vivo upon patient staging in a clinical scanner (1.5 Tesla) and 
confronted with standard visual analysis by specialized radiologists. 
Part 2: Locally-advanced rectal cancer patients may have no signs of viable tumour after 
neoadjuvant therapy. “Watch-and-Wait” programs were developed to place such patients under 
strict surveillance instead of submitting them to likely unnecessary mutilating surgery. MR imaging 
plays a fundamental role in the selection and follow-up of such patients and an educational review 
of the methods upon which they rely is provided.  
To identify a clinical complete response in the early period after neoadjuvant therapy may be less 
important than to identify a clinical complete response that will be sustained over time, given 
complete responders that regrow present with a higher rate of distant metastases. Three new 
imaging patterns were reported for that purpose and are presented as original research – the split 
scar sign, the tumour scar depth angle difference and the scar thickness at second assessment. 
Susceptibility Perturbation MR Imaging and Higher-order Diffusion MR Imaging may allow more 
accurate lymph node staging. As such, they may have the potential to improve risk stratification and 
patient selection for neoadjuvant therapy. The split scar sign, the scar depth angle difference and 
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the scar thickness at second assessment are simple tools to analyze on post-neoadjuvant therapy 
MR imaging that may aid in patient selection for “Watch-and-Wait” versus curative resection. 
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9 
4.1 MRI of rectal cancer – Relevant anatomy and staging keypoints 
Pelvic MR imaging is the pillar of rectal cancer staging and patient risk stratification. It therefore 
constitutes the basis for optimal multidisciplinary patient management. A thorough and systematic 
knowledge of the relevant anatomy, the key staging features and the particularities of early, low 
and mucinous tumours is mandatory for MR imaging interpretation and is provided in the following 
educational review.  
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4.2. Why is there a need to improve lymph node staging? 
Lymph node involvement is one of the key determinants of patient prognosis in oncology. It 
corresponds to the middle letter (N) of the widespread TNM (tumour – lymph nodes – metastasis) 
staging system defined by the American Joint Committee on Cancer and the International Union 
Against Cancer. Prognostic stratification based on TNM relies on the evaluation of the extension of 
the primary tumour and on the count of involved locoregional lymph nodes within the surgically 
resected specimen. However, in the particular case of rectal cancer, before submitting a patient to 
a potentially mutilating and morbid surgery, a question arises: Will this patient benefit from 
neoadjuvant radiotherapy and/or chemotherapy? The answer relies on MR imaging-based risk 
stratification and guidelines are available to establish which patients present with locally-advanced 
rectal cancer. They have at least two things in common: Lymph node involvement is part of the 
equation, and patients with rectal cancer considered locally-advanced have an indication for 
neoadjuvant therapy [its beneficial and superior impact compared to post-operative regimens on 
local recurrence and disease-free survival has been demonstrated in several seminal randomized 
clinical trials (1-6)]. On the other hand, non-locally-advanced rectal cancer patients will not benefit 
from neoadjuvant therapy - they will pointlessly endure significant adverse effects, surgery will be 
delayed and become technically more difficult, and they will more likely suffer from post-operative 
morbidity than if they go straight to surgery.  
Standard MR imaging is quite accurate regarding two of the major pillars for risk stratification - T 
stage and mesorectal fascia involvement (7,8). However, with respect to lymph node involvement, 
performance is poor and in a large multicentric study involving 100.211 patients has even been 
compared to flipping a coin (8,9). Diagnostic performance may improve significantly with injectable 
contrast agents such as the strictly intravascular Gadofosveset® or the ultrasmall 
superparamagnetic iron oxide particles (USPIO), both with AuROC above 0.90 (10,11). The latter are 
captured by macrophages and transported to normal lymphatic tissue. T2* weighted gradient echo 
images will then detect a decrease in signal intensity in normal lymphatic tissue due to local field 
inhomogeneity induced by iron, whereas in tumour tissue, such signal decrease will not be observed 
(11). However, despite impressive reported results, these contrasts are cumbersome to use, have 
relevant adverse effects and are not commercially available (11).  
Gradient echo MR imaging may also be used without USPIO administration for the differentiation 
between benign and malignant lymph nodes. The physiological reasoning is that macrophages 
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naturally engulf endogenous magnetic field disturbing substances, namely blood degradation 
products, whereas cancer cells do not (12,13). Another promising technique, which explores the 
restriction to the movement of water molecules, is diffusion weighted MR imaging (DWI). Dense, 
cell-rich tumour contains more barriers to the diffusion of water than sparsely cellular normal tissue. 
This property has been explored extensively in human imaging. However, normal lymphatic tissue 
is also characterized by high cellularity and the apparent diffusion coefficient (ADC), the simplest 
and best-known quantitative DWI-derived parameter, shows a significant overlap between benign 
and malignant lymph nodes. New and more elaborate post-processing DWI models are now 
available that may make way for a better understanding of tissue architecture and for a more 
accurate differential diagnosis (14).  
The purpose of the following original research is to explore new acquisition and post-processing 
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4.3. Susceptibility perturbation imaging maps tumor infiltration into mesorectal 
lymph nodes
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4.4. Higher-order diffusion MRI characterization of mesorectal lymph nodes in 
rectal cancer 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
45 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
48 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
50 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
53 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
54 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
56 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
57 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               




                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
61 
4.5 Advances in knowledge 
We developed two new methods to distinguish normal from tumour-infiltrated mesorectal lymph 
nodes in rectal cancer - Susceptibility Perturbation MR Imaging and Higher-order Diffusion MR 
Imaging. We first tested the methods ex-vivo at ultra-high field (16.4 Tesla) and co-registered the 
high resolution “virtual histology” images with those of actual histology for microarchitectural 
comprehension. Then, we tested the node-by-node diagnostic accuracy in-vivo, upon patient 
staging, in a 1.5 Tesla clinical scanner. Finally, we confronted it with visual analysis by specialized 
radiologists according to current European Society of Gastrointestinal and Abdominal Radiology 
guidelines, to determine their added value. We will now summarize the advances in knowledge for 
each new method: 
 
Susceptibility Perturbation MR Imaging (SPI) 
- SPI accurately improved specificity toward microstructural lymph node characterization – 
the significant quantitative differences in its extracted parameters were, at least in part, 
explained by differences in cellularity and cell size between benign and malignant tissue, as 
opposed to iron content or oxygenation state.  
- Malignant lymph node tissue presented with 3 main phenotypes at histology: solid 
infiltration, necrosis and desmoplasia, which in turn translated into variations of the SPI 
contrast.  
- SPI increased the accuracy of lymph node characterization upon clinical staging at 1.5 Tesla, 
with a significant improvement in sensitivity compared to standard visual assessment by 
specialized radiologists. 
- Combined SPI + radiologist analysis reached AuROCs of 0.80/0.87, coming close to those of 
Gadofoveset® or USPIO-based assessment and without their inconveniences.  
 
 Higher-order diffusion MR imaging 
-          The 8 compartment models used to analyze the rich ex-vivo diffusion MR imaging 
data showed an important spatial variation across lymph node tissue. 
-           The ZeppelinSphere model, which accounts for both diffusion anisotropy and restriction 
in the tissue, provided overall the best fit and translated into significant differences between 
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benign and malignant tissue, which we could at least in part justify based on differences in 
cell size and density. 
-          Intravoxel-Incoherent-Motion–Kurtosis was the most suitable of the 4 models tested in-
-vivo, with an AuROC of 0.80 for the differentiation between benign and malignant tissue, 
superior to visual analysis by specialized radiologists.  
-          ADC, the simplest and best known model in clinical practice, showed the worst 
performance for the in-vivo dataset. 
-          Combined Intravoxel-Incoherent-Motion–Kurtosis + radiologist evaluation resulted in 
AuROCS of 0.89/0.80, once again coming close to those of Gadofoveset® or USPIO-based 
assessment and without their inconveniences. 
Susceptibility Perturbation MR Imaging and Higher-order Diffusion MR Imaging were able to 
characterize and differentiate benign from malignant lymph nodes in rectal cancer, both ex-vivo at 
16.4 Tesla and in-vivo at 1.5 Tesla. These new methods may have the potential to aid in risk 
stratification and patient selection for neoadjuvant therapy. 
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5.1 Re-staging and follow-up of rectal cancer patients with MR imaging when 
“Watch-and-Wait” is an option – A practical guide 
Total mesorectal excision, as proposed by Heald et al in 1982, is now standard surgery for rectal 
cancer patients and contributed to an increase in 5-year survival rates from 30% to 68% and to a 
decrease in local recurrence from 40% to less than 5% (1). However, the morbidity of standard 
radical surgery is significant, with over a third of patients reporting urologic and/or sexual 
dysfunction and/or fecal incontinence (2,3). A series of landmark clinical trials support the use of 
neoadjuvant therapy to further improve oncologic outcomes in locally-advanced rectal cancer 
patients. It leads to a variable percentage of pathologic complete responses, ranging from 10 to 40% 
for long-course chemoradiation and 8–9% for short-course radiotherapy when surgery is performed 
4–8 weeks after the end of radiotherapy (4–12). The need for radical surgery in such patients with 
no evidence of residual disease has been questioned, and a non-operative “Watch-and-Wait” 
approach is now established policy in dedicated centers worldwide (13). This approach demands a 
strict surveillance protocol based largely on endoscopy and MR imaging given regrowth on follow-
up occurs in about one fourth of cases (14). In the following educational review, a practical guide 
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5.2 Why is there a need to improve the early identification of sustained complete 
responders? 
Current guidelines recommend rectal cancer response assessment to be based on endoscopy and 
MR imaging if organ-preservation is to be considered (1,2). Biopsies are not routinely employed, 
given, on one hand, the inherent sampling errors and, on the other hand, the false-positive cases 
due to the non-immediate process of tumour cell death after radiotherapy (3).  
The endoscopic evaluation of residual mucosal abnormality was the earliest criterium used to 
identify patients with a complete response. Indeed, normalization of the mucosa on endoscopy is 
considered very specific (4-7). However, residual mucosal abnormalities are present in the majority 
(88– 89%) of unrecognized complete responders (3,8) and even in 61–74% of surgical specimens 
with a complete response. As such, many complete responses may be missed based on this method 
alone (8,9). Another limitation is that it does not allow in-depth scar or nodal disease observation 
having therefore the potential to, on the other side of the spectrum, miss residual disease in such 
locations (4).  
Assessment of the relative proportion of intermediate signal intensity at the tumour bed on T2-
weighted imaging (mrTRG or a variant) is the most widely accepted MR imaging method to assess 
response to neoadjuvant therapy. It has demonstrated the ability to predict patients’ long-term 
survival in the MERCURY trial (10). However, according to the same research group, its specificity 
for pathologic complete response is relatively low (62.8%) and agreement with pathology is only fair 
(k = 0.24) (11). Its summary sensitivity and specificity for complete response are, according to a 
recent meta-analysis by Park et al, 0.49 (95%CI,0.33–0.65) and 0.86 (95%CI,0.74–0.93), respectively 
(12). Reported interobserver agreement is variable, ranging from poor to good, likely due to both 
the diverseness in assessment criteria and the heterogeneity of tumour response patterns (4,13-
15). Adding diffusion-weighted imaging (DWI) to standard T2-weighted MR imaging assessment 
improves accuracy and is recommended by all international guidelines, but this method is highly 
dependent on patient preparation, acquisition protocol and reader’s experience (16-19).  
Artificial intelligence tools are now trendy in radiology journals. Radiomics analysis of combined T2-
weighted imaging, DWI and contrast-enhanced T1-weighted imaging of pre-treatment MR imaging, 
for instance, performed extremely well for the identification of complete response, with specificity 
of 0.89 and AuROC values of ≥ 0.94, in a series of 186 patients who underwent surgery as curative 
treatment (20). However, this and other similar promising methods still rely on time-consuming 
image segmentation by radiologists (conveying a selection bias for data analysis), are based on 
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complex and sometimes flawed statistical methods, and are still missing validation, particularly with 
adequate external datasets (21).  
But perhaps even more important than to identify a complete response after neoadjuvant therapy 
is to predict whether that clinical complete response will be sustained over time. We know that 
regrowth will occur in roughly one fourth of cases (22) and is practically always salvageable with 
surgery, so in itself, it might not be a problem. However, Smith et al and Fernandez et al found an 
excess rate of distant metastases in these patients compared to sustained complete responders, of 
36% vs 1% and 17.8% vs 4.9%, respectively. Whether a higher risk is already present at baseline or 
metastases emerge as a consequence of the uncontrolled primary tumour is not yet known (22,23).  
A combined morphologic and functional visual pattern approach based on T2-weighted and DWI 
MR imaging provided a positive predictive value and a specificity for a sustained complete response 
over time of 87% and 94%, respectively, in a series of 222 patients. However, mucinous tumours 
were excluded from the analysis and they may constitute up to 10% of all rectal cancer cases (25).  
In summary, optimal management requires the early differentiation of rectal cancer patients who 
will need surgery for cure from those who will sustain a complete response. Standard assessment 
tools, namely endoscopy, mrTRG and DWI appear insufficient for that purpose (5,16,24). Driven by 
the need for new methods that may be applicable to all rectal cancer patients, including those with 
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5.3. The split scar sign as an indicator of sustained complete response after 
neoadjuvant therapy in rectal cancer 
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5.4.  Early conformational changes at tumour bed and long term response after 
neoadjuvant therapy in rectal cancer 
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5.5. Advances in knowledge  
 
We described three new T2-weighted MR imaging methods to distinguish patients who will sustain 
a complete response over time from those who won´t, in the early period that follows radiotherapy 
– the split scar sign, the scar depth angle difference and the scar thickness at second assessment. 
The analysis was performed retrospectively, blindly and independently by two specialized 
radiologists, to all eligible patients in our prospectively-recorded rectal cancer database. 
Interobserver agreement was assessed and the new methods were confronted with standard 
assessment tools, namely endoscopy, mrTRG (or similar) and DWI, to determine their added value. 
We will now summarize the advances in knowledge for each of them: 
 
Split Scar Sign  
- The split scar sign is a morphologic pattern visible on high-resolution T2-weighted MR 
imaging in rectal cancer patients after neoadjuvant therapy. It therefore does not require 
any changes to standard protocol. 
-  At first restaging pelvic MR imaging (mean: 9.1 weeks after the end of radiotherapy), the 
split scar sign identified patients who sustained a complete response with very high 
specificity (0.97) and positive predictive value (0.93–0.94). 
- Its interobserver agreement was substantial (k=0.69, p<0.01). 
- The split scar sign performed better than conventional T2-weighted (p=0.19/0.75) and DWI 
(p=0.18/<0.01) assessments, and also better than endoscopy (p=0.59). 
- The split scar sign may have the potential to improve patient selection for “Watch-and-Wait” 
after neoadjuvant therapy in rectal cancer.  
 
 Scar Depth Angle Difference 
- The scar depth angle difference is based on simple measurements on T2-weighted MR 
imaging by specialized radiologists and as such does not imply any change in standard re-
staging acquisition protocol. 
- A tumour scar depth angle increase > 21º between the first and second MR Imaging 
assessments post-neoadjuvant therapy (med: 10 weeks and 23 weeks after the end of 
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radiotherapy, respectively) was highly specific for a non-sustained complete response 
(specificity=0.91/0.94). 
-  Inter-observer agreement was good (intraclass correlation coefficient of 0.65). 
- Its performance was superior to that of the retrieved endoscopy and mrTRG assessments. It 
was equivalent to that of retrieved DWI but all false positive DWI evaluations were negative 
for scar depth angle change, boding well for a combined analysis. 
 
Scar thickness at second assessment 
- The scar thickness at second assessment (med: 23 weeks after the end of radiotherapy) is 
based on simple measurements on T2-weighted MR imaging by specialized radiologists. 
- A thickness >10mm indicated a non-sustained complete response with very high specificity 
(0.91/0.94). 
-  Inter-observer agreement was excellent (intraclass correlation coefficient of 0.84). 
- Its performance was superior to that of the retrieved endoscopy and mrTRG assessments. It 
was equivalent to that of retrieved DWI but all false positive DWI evaluations were negative 
for scar thickness at second assessment, boding well for a combined analysis. 
 
The split scar sign, the scar depth angle difference and the scar thickness at second assessment are 
3 promising imaging biomarkers to differentiate “true” complete responders from patients who will 
require surgery for cure, in the early period after neoadjuvant therapy. They are based on simple 
analysis of standard MR T2-weighted images, which may ease their clinical implementation, should 
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6. Summary and perspectives 
The present thesis focused on MR imaging in rectal cancer and was divided in two parts: In the first 
part, we targeted the “Achilles heel” of rectal cancer staging – lymph node classification. We 
elaborated on the development of two new methodologies ex-vivo at ultra-high MR field strength 
and in robust co-registration with histology, named Susceptibility Perturbation MR Imaging and 
Higher-order Diffusion MR Imaging.  We then described the translation of the experiments to an in-
vivo context, at 1.5 Tesla during patient staging, and their added value for lymph node classification; 
In the second part, we pinpointed the re-staging of locally-advanced rectal cancer after neoadjuvant 
therapy. We described 3 simple new methods, based on the visual analysis of standard high 
resolution T2-weighted images, to differentiate sustained complete responders from non-sustained 
complete responders.  These methods, named the split scar sign, the scar depth angle difference 
and the scar thickness at second assessment, may have the potential to aid in patient selection for 
“Watch-and-Wait” versus curative resection.  
The next steps regarding the research presented should be to test the methods prospectively at 
multiple institutions, using different MR equipment and acquisition protocols, with adequate 
validation: Susceptibility Perturbation MR Imaging and Higher-order Diffusion MR Imaging will 
require careful co-registration with histology; the split scar sign, the scar depth angle difference and 
the scar thickness at second assessment will require co-registration with pathology and/or long-
term “Watch-and-Wait” follow-up. The impact of the use of any of these methods on long-term 
patient outcome should also be assessed. 
The content of this thesis is not trendy, given it emerges in the middle of a deluge of radiology 
research on artificial intelligence and, when it comes to oncology, radiomics is a particularly 
appealing field. The latter consists of the extraction of a large number of quantitative features from 
radiological images in search of new signatures to improve tumour phenotyping and to predict and 
evaluate response to therapy. Although it is underlined with the premise that radiological images 
reflect pathophysiology, most of the quantitative features are agnostic, meaning they fail to be 
appreciated by the human eye. To jump beyond promising into clinical practice, these powerful 
tools will require a process of validation that includes some form of biological understanding. As 
such, a combined analysis with conventional semantics is encouraged, as well as integration with 
clinical data such as histology, immunohistochemistry, mutational status, immunologic phenotype, 
habitat subregional mapping and others. Not only will the integration provide more intelligible 
answers, but also increase specificity towards patient management. We believe radiomics and other 
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artificial intelligence algorithms will not halt innovation in image acquisition methods, given the 
latter can only feed the former with additional information. Also, we believe these algorithms may 
greatly assist radiologists on a relatively short run, complementing their conventional semantic 
analysis and their reasonableness to deal with the unexpected.  
 
